Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

European Respiratory Society

This page shows the latest European Respiratory Society news and features for those working in and with pharma, biotech and healthcare.

AZ hopes dosing will differentiate its severe asthma therapy

AZ hopes dosing will differentiate its severe asthma therapy

The UK pharma group reported the results of two studies at the European Respiratory Society (ERS) in London, which showed the interleukin-5 (IL-5) inhibitor was able to reduce attacks

Latest news

  • Roche says Esbriet boosts survival in pulmonary fibrosis Roche says Esbriet boosts survival in pulmonary fibrosis

    Roche says Esbriet boosts survival in pulmonary fibrosis. Positive results due to be presented at European Respiratory Society . ... deal. The new data - due to be presented to doctors for the first time at the European Respiratory Society (ERS)

  • Boehringer in breach over beer drinking, lederhosen presentation Boehringer in breach over beer drinking, lederhosen presentation

    standards. The breach comes after a pulmonologist working in Germany complained about a scientific symposium organised by Boehringer at the European Respiratory Society (ERS) Congress, held in Munich last year. ... Boehringer currently markets the

  • GSK sees COPD future in triple therapy GSK sees COPD future in triple therapy

    The performance of GSK's respiratory portfolio dragged down group revenues as a whole last year, and GSK is now banking on a series of new products launches - including LAMA/LABA ... One set back for the triple therapies came last year, however, when a

  • Questions raised about affordability of asthma antibodies Questions raised about affordability of asthma antibodies

    GlaxoSmithKline (GSK) and Teva presented positive phase III trials of their respective anti-IL-5 candidates mepolizumab and reslizumab at this week's European Respiratory Society (ERS) meeting in Munich, showing

  • Boehringer's Spiriva cleared for asthma in EU Boehringer's Spiriva cleared for asthma in EU

    Approval by the European Medicines Agency (EMA) was based on the results of a phase III trial programme - called UniTinA-asthma - that collectively showed that Spiriva reduced the risk of severe ... Boehringer has also presented new data at the European

More from news
Approximately 1 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Integrating digital: developing a social conference Integrating digital: developing a social conference

    More recently the company has been forging ahead in its use of tweetchats - during the European Respiratory Society Congress in 2013 it used this forum to spark conversations on chronic obstructive ... More recently it engaged digital efforts for a

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Quick links

Infographics

Multimedia